ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 19 filers reported holding ACHILLES THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,447,051 | -87.2% | 1,607,834 | -67.9% | 0.03% | -88.0% |
Q3 2022 | $11,333,000 | -10.3% | 5,014,687 | 0.0% | 0.24% | -28.2% |
Q2 2022 | $12,637,000 | -14.3% | 5,014,687 | 0.0% | 0.34% | +4.7% |
Q1 2022 | $14,743,000 | -41.3% | 5,014,687 | 0.0% | 0.32% | -27.3% |
Q4 2021 | $25,124,000 | -35.7% | 5,014,687 | 0.0% | 0.44% | -18.1% |
Q3 2021 | $39,064,000 | -20.4% | 5,014,687 | 0.0% | 0.54% | -31.3% |
Q2 2021 | $49,094,000 | +113.6% | 5,014,687 | +261.1% | 0.79% | +127.1% |
Q1 2021 | $22,986,000 | – | 1,388,888 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 11,086,909 | $10,087,979 | 15.03% |
Artal Group S.A. | 2,255,375 | $2,052 | 0.09% |
Redmile Group, LLC | 1,608,089 | $1,463,200 | 0.07% |
Forefront Analytics, LLC | 78,169 | $71,126 | 0.04% |
Baker Brothers Advisors | 2,557,149 | $2,326,750 | 0.01% |
Point72 Asset Management, L.P. | 1,413,809 | $1,286,425 | 0.00% |
XTX Topco Ltd | 21,084 | $19,184 | 0.00% |
Coppell Advisory Solutions LLC | 1,000 | $5,560 | 0.00% |
Renaissance Technologies | 437,528 | $398 | 0.00% |
JPMORGAN CHASE & CO | 989 | $900 | 0.00% |